This ASX 200 gold stock could be a top buy after a 'transformational' year

Bell Potter is bullish on this name. Let's find out why.

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

With the gold price booming again, now could be a good time to buy the ASX 200 gold stock in this article.

This is especially the case after a "transformational" year according to the team at Bell Potter.

A young man punches the air in delight as he reacts to great news on his mobile phone.

Image source: Getty Images

Which ASX 200 gold stock?

The stock in question is Alkane Resources Ltd (ASX: ALK).

Bell Potter was impressed with the company's performance in FY 2026, highlighting that it delivered record results and growth across all key metrics. It said:

ALK reported an FY26 financial result that delivered record results and substantial YoY growth across all key financial metrics, together with a maiden dividend of 2cps. This followed the merger with Mandalay Resources (MND:TSX), completed in August 2025 and consecutive quarters of record production from the combined portfolio. Key metrics included revenue of $936m (vs BPe $946m), EBITDA of $471m (vs BPe $473m), and NPAT $229m (vs BPe $238m). 

The maiden dividend of 2cps ($27m payout) was accompanied by the announcement of a share buyback of up to $50m, in a further commitment to returning capital to shareholders and a signal on the value ALK sees in its paper. EBITDA margins lifted from 36% to 50% YoY on higher gold and antimony prices, as well as the dilution of ALK's out-of-the-money hedge book. At end FY26, ALK held cash and bullion of $439m (vs $190m at completion of the MND merger) and no drawn bank debt. FY27 guidance was reaffirmed, for 163-177koz at AISC of A$2,900-$3,200/oz, implying steady production and ~5% higher costs YoY.

Time to buy

According to the note, in response to the results, Bell Potter has retained its buy rating on the ASX 200 stock with an improved price target of $2.15.

Based on its current share price of $1.85, this implies potential upside of 16% for investors over the next 12 months.

Commenting on its buy recommendation, Bell Potter said:

EPS changes in this report are: FY27: -3%; FY28: -2% and FY29: -5%, reflecting a lower antimony price, higher CAPEX and D&A over the medium term. We also incorporate a sustainable dividend into our modelled assumptions. ALK offers multi-mine gold and antimony exposure across three attractive jurisdictions with a strong balance sheet and available liquidity that provides a platform for growth. Our Target Price lifts 2% to $2.15/sh. Valuation metrics remain undemanding and we retain our Buy recommendation.

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Broker Notes

Woman analysing data.
Broker Notes

What is Bell Potter saying about EOS shares after its results?

The broker remains bullish on this rapidly growing stock.

Read more »

Happy man on a supermarket trolley full of groceries with a woman standing beside him.
Broker Notes

Are Coles shares a buy after its results?

Bell Potter has given its view on the supermarket giant.

Read more »

A woman in a red dress holding up a red graph.
Broker Notes

3 ASX shares Macquarie says will return 23% to 49%

These shares are well-positioned for a strong year.

Read more »

Woman and man at work looking at data on a tablet at work.
Broker Notes

Buy, hold, sell: Judo Capital, Healius, BHP shares

Morgans has issued new notes on several stocks including BHP, which hit a new record today.

Read more »

Woman with her kitten on a laptop in her home office.
Broker Notes

Buy, hold, sell: Bendigo and Adelaide Bank, PLS, EOS shares

These three ASX shares posted their FY26 results this week. Find out what brokers tip next.

Read more »

Medical workers examine an x-ray or scan in a hospital laboratory.
Broker Notes

Bell Potter says this ASX biotech could nearly double in value

The US market is starting to open up for this company.

Read more »

Two work colleagues looking at a laptop and discussing something.
Broker Notes

Buy, hold, sell: DigiCo Infrastructure REIT, CBA, Telstra shares

Amid another day in the green for the ASX 200, experts reveal their new ratings.

Read more »

A scientist in a white coat and glasses puts her arms in the air in a sign of strength and success.
Broker Notes

This ASX small-cap healthcare stock is tipped to double in value

This company has a good base to build on.

Read more »